We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cancer Research UK Identifies Novel Role for CD169+ Macrophages in Activating Invariant Natural Killer T Cells

Product News   Feb 09, 2011

 
Cancer Research UK Identifies Novel Role for CD169+ Macrophages in Activating Invariant Natural Killer T Cells
FURTHER INFORMATION
 
 
 

Related Product News

Restek Wins Award for Innovative Use of Its New Software

Product News

Restek accepted the “The Trailblazers–Team Award” during the IFS World Conference for its innovative implementation of IFS Applications software.

READ MORE

Repositive Unveils Molecular Search Functionality for Its Cancer Models Platform

Product News

Repositive has unveiled molecular search functionality for its Cancer Models Platform at ELRIG Drug Discovery.

READ MORE

Advances in Bavarian Nordic’s Cancer Immunotherapy Platform

Product News

A paper discussing recent preclinical advances of Bavarian Nordic’s novel cancer immunotherapy platform has been published in Nature Communications.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE